Found 74 results. Export: Tagged | XML
Filters: keyword is dosage  [Clear All Filters]
2004
Swart, E.L., Zuideveld, K.P., de Jongh, J., Danhof, M., Thijs, L.G., van Strack Schijndel, R.M. , Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients, Br J Clin Pharmacol, vol. 57, no. 2, pp. 135-45. DOI
Nugroho, A.K., Li, G., Grossklaus, A., Danhof, M., Bouwstra, J.A. , Transdermal iontophoresis of rotigotine: influence of concentration, temperature and current density in human skin in vitro, J Control Release, vol. 96, no. 1, pp. 159-67. DOI
2003
Li, G.L., Grossklaus, A., Danhof, M., Bouwstra, J.A. , Iontophoretic R-apomorphine delivery in combination with surfactant pretreatment: in vitro validation studies, Int J Pharm, vol. 266, no. 1-2, pp. 61-8. DOI
Li, G.L., Danhof, M., Frederik, P.M., Bouwstra, J.A. , Pretreatment with a water-based surfactant formulation affects transdermal iontophoretic delivery of R-apomorphine in vitro, Pharm Res, vol. 20, no. 4, pp. 653-9.
2002
Knibbe, C.A., Melenhorst-de Jong, G., Mestrom, M., Rademaker, C.M., Reijnvaan, A.F., Zuideveld, K.P., Kuks, P.F., van Vught, H., Danhof, M. , Pharmacokinetics and effects of propofol 6% for short-term sedation in paediatric patients following cardiac surgery, Br J Clin Pharmacol, vol. 54, no. 4, pp. 415-22. DOI
Li, G.L., van der Geest, R., Chanet, L., van Zanten, E., Danhof, M., Bouwstra, J.A. , In vitro iontophoresis of R-apomorphine across human stratum corneum. Structure-transport relationship of penetration enhancement, J Control Release, vol. 84, no. 1-2, pp. 49-57. DOI
Swart, E.L., van der Hoven, B., Groeneveld, A.B., Touw, D.J., Danhof, M. , Correlation between midazolam and lignocaine pharmacokinetics and MEGX formation in healthy volunteers, Br J Clin Pharmacol, vol. 53, no. 2, pp. 133-9. DOI
Knibbe, C.A., Zuideveld, K.P., DeJongh, J., Kuks, P.F., Aarts, L.P., Danhof, M. , Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%, Clin Pharmacol Ther, vol. 72, no. 6, pp. 670-84. DOI
2001
Li, G.L., Danhof, M., Bouwstra, J.A. , Effect of elastic liquid-state vesicle on apomorphine iontophoresis transport through human skin in vitro, Pharm Res, vol. 18, no. 11, pp. 1627-30.
Li, G.L., Danhof, M., Bouwstra, J.A. , Lontophoretic delivery of apomorphine in vitro: physicochemic considerations, Pharm Res, vol. 18, no. 11, pp. 1509-13.
1999
Knibbe, C.A., Voortman, H.J., Aarts, L.P., Kuks, P.F., Lange, R., Langemeijer, H.J., Danhof, M. , Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection, Br J Clin Pharmacol, vol. 47, no. 6, pp. 653-60. DOI
Cox, E.H., Langemeijer, M.W., Gubbens-Stibbe, J.M., Muir, K.T., Danhof, M. , The comparative pharmacodynamics of remifentanil and its metabolite, GR90291, in a rat electroencephalographic model, Anesthesiology, vol. 90, no. 2, pp. 535-44.
van Laar, T., Van der Geest, R., Danhof, M. , Future delivery systems for apomorphine in patients with Parkinson's disease, Adv Neurol, vol. 80, pp. 535-44.
1998
van Laar, T., van der Geest, R., Danhof, M., Bodde, H.E., Goossens, P.H., Roos, R.A. , Stepwise intravenous infusion of apomorphine to determine the therapeutic window in patients with Parkinson's disease, Clin Neuropharmacol, vol. 21, no. 3, pp. 152-8.
Cox, E.H., Knibbe, C.A., Koster, V.S., Langemeijer, M.W., Tukker, E.E., Lange, R., Kuks, P.F., Langemeijer, H.J., Lie, A.H.L., Danhof, M. , Influence of different fat emulsion-based intravenous formulations on the pharmacokinetics and pharmacodynamics of propofol, Pharm Res, vol. 15, no. 3, pp. 442-8.
van der Geest, R., Danhof, M., Bodde, H.E. , Validation and testing of a new iontophoretic continuous flow through transport cell, J Control Release, vol. 51, no. 1, pp. 85-91. DOI
1997
van der Geest, R., Kruger, P., Gubbens-Stibbe, J.M., van Laar, T., Bodde, H.E., Danhof, M. , Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease, J Chromatogr B Biomed Sci Appl, vol. 702, no. 1-2, pp. 131-41.
van der Geest, R., Danhof, M., Bodde, H.E. , Iontophoretic delivery of apomorphine. I: In vitro optimization and validation, Pharm Res, vol. 14, no. 12, pp. 1798-803.
van der Geest, R., van Laar, T., Gubbens-Stibbe, J.M., Bodde, H.E., Danhof, M. , Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease, Pharm Res, vol. 14, no. 12, pp. 1804-10.
Snoeck, E., Piotrovskij, V., Jacqmin, P., Lins, R.L., Van Peer, A., Danhof, M., Woestenborghs, R., Van Gool, R., Dupont, A.G., Heykants, J. , Population analysis of the non-linear red blood cell partitioning of draflazine following various infusion durations, Eur J Clin Pharmacol, vol. 53, no. 1, pp. 57-63.
1996
van Laar, T., Neef, C., Danhof, M., Roon, K. I, Roos, R.A. , A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease, Mov Disord, vol. 11, no. 6, pp. 633-8. DOI
1995
Mathot, R.A., Van der Wenden, E.M., Soudijn, W., AP, I.J., Danhof, M. , Deoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo, Br J Pharmacol, vol. 116, no. 3, pp. 1957-64.
van Laar, T., Jansen, E.N., Neef, C., Danhof, M., Roos, R.A. , Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories, Mov Disord, vol. 10, no. 4, pp. 433-9. DOI
1994
de Lange, E.C., Danhof, M., de Boer, A.G., Breimer, D.D. , Critical factors of intracerebral microdialysis as a technique to determine the pharmacokinetics of drugs in rat brain, Brain Res, vol. 666, no. 1, pp. 1-8.
Vinks, A.A., Touw, D.J., Heijerman, H.G., Danhof, M., de Leede, G.P., Bakker, W. , Pharmacokinetics of ceftazidime in adult cystic fibrosis patients during continuous infusion and ambulatory treatment at home, Ther Drug Monit, vol. 16, no. 4, pp. 341-8.
123